# Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy

> **NCT00933816** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kindai University** · enrollment: 37 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** sorafenib, cisplatin, fluorouracil

## Key facts

- **NCT ID:** NCT00933816
- **Lead sponsor:** Kindai University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2010-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933816, "Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00933816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*